Sequel
- Biotech or pharma, therapeutic R&D
- Medical device or technology
Fierce 15 Class of 2025 Selection
Sequel has developed a completely portable on-body drug delivery system that can subcutaneously deliver medications with exquisite precision to patients at home or on the go in a convenient and discrete device.
Sequel's device has been cleared by the FDA and is on the market for two applications to date and can be adapted to solve a wide variety of challenges such as:
1) Deliver large volume therapies subcutaneously at home
2) Precisely deliver therapies down to 0.5 microliters - critical for potent therapies or those with a narrow therapeutic index
3) Continuously administer a therapy 24 hours a day, 7 days a week or programmable intermittent delivery over longer periods of time, as warranted
4) Development of closed loop systems to manage treatment of disease (eg automated insulin delivery)
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}